[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337833-105":59,"doc-detail-337833-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oncolytic-adenovirus-encoding-lhpp-exerts-potent-antitumor-effect-in-lung-cancer","Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer","","The study investigates a novel recombinant oncolytic adenovirus, GD55-LHPP, designed to deliver the tumor suppressor gene LHPP for lung cancer treatment. LHPP expression is found to be reduced in lung cancer cells and clinical lung cancer tissues versus normal counterparts, while GD55-LHPP efficiently restores LHPP expression in lung cancer cells. In vitro and in vivo results show that GD55-LHPP suppresses tumor cell proliferation, promotes caspase- and autophagy-related antitumor mechanisms, and inhibits xenograft tumor growth while prolonging survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncolytic-adenovirus-encoding-lhpp-exerts-potent-antitumor-effect-in-lung-cancer/337833/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncolytic-adenovirus-encoding-lhpp-exerts-potent-antitumor-effect-in-lung-cancer/337833.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is GD55-LHPP and what is its therapeutic goal?","Question",{"text":112,"@type":113},"GD55-LHPP is a recombinant oncolytic adenovirus where GD55 carries the LHPP gene. Its goal is to mediate LHPP expression in lung cancer cells and suppress tumor growth.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do the results compare LHPP expression in lung cancer versus normal tissues?",{"text":117,"@type":113},"LHPP expression is lower in lung cancer cells and in clinical lung cancer tissues compared with normal cells and tissues, indicating an association between LHPP loss and lung cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanisms does GD55-LHPP use to inhibit lung cancer progression?",{"text":121,"@type":113},"GD55-LHPP induces stronger apoptosis through caspase signal pathway activation and also activates an autophagy-related signal pathway.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337833,1790104111,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nOncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer  \nYaru Zhao1,2, Huihui Liu1, Qi Zhan1, Hao Jin1, Yiqiang Wang3, Hui Wang2, Biao Huang1, Fang Huang4, Xiaoyuan Jia1*, Yigang Wang1* & Xiaoyan Wang2*  \nLHPP has been shown to be a new tumor suppressor, and has a tendency to be under-expressed in a variety of cancers. Oncolytic virotheray is a promising therapeutics for lung cancer in recent decade years. Here we successfully constructed a new recombinant oncolytic adenovirus GD55-LHPP and investigated the effect of GD55-LHPP on the growth of lung cancer cells in vitro and in vivo. The results showed that LHPP had lower expression in either lung cancer cells or clinical lung cancer tissues compared with normal cells or tissues, and GD55-LHPP effectively mediated LHPP expression in lung cancer cells. GD55-LHPP could effectively inhibit the proliferation of lung cancer cell lines and rarely affected normal cell growth. Mechanically, the oncolytic adenovirus GD55-LHPP was able to induce stronger apoptosis of lung cancer cells compared with GD55 through the activation of caspase signal pathway. Notably, GD55-LHPP also activated autophagy-related signal pathway. Further, GD55-LHPP efficiently inhibited tumor growth in lung cancer xenograft in mice and prolonged animal survival rate compared with the control GD55 or PBS. In conclusion, the novel construct GD55-LHPP provides a valuable strategy for lung cancer-targeted therapy and develop the role of tumor suppress gene LHPPin lung cancer gene therapy.  \nAccording to the latest statistics, the incidence and mortality rates of lung cancer rank first in all cancer types throughout the worldwide, and the 5 year overall survival rate is less than 20%1,2.Current treatment strategies such as surgery, chemotherapy, radiotherapy, and molecular targeting therapy as well as immunotherapy are ineffective against advanced tumors. Therefore, there is still an urgent need to search novel approaches to treat lung cancer.  \nOncolytic virotherapy has recently been considered as one of the most promising strategies for the treatment of solid tumors due to its tumor-targeting ability and high efficiency3,4. Our group has been working on Cancertargeting gene-virotherapy (CTGVT) through inserting anti-tumour genes into oncolytic virus vectors, such as adenoviral vector and vaccinia vector5,6, which has obtained better anti-tumour effect compared to oncolytic virus alone and gene therapy alone.  \nGP73, is a Golgi glycoprotein, also called GOLPH2 and is upregulated in a wide range of cancers7,8. It is an excellent candidate marker for hepatocellular carcinoma, and its specificity is even better than that ofthe hepatocellular carcinoma marker AFP9. Previously, we constructed a GP73-regulated oncolytic adenovirus (GD55) based on ZD55 of CTGVT, exhibits a stronger oncolytic effect compared to common oncolytic adenovirus inhuman liver cancer stem-like cells10, human prostate cancer stem-like cells5, and hepatocellular carcinoma11either in vivo or in vitro. It showed that GD55 has an excellent antitumor potential as oncolytic virus vector to deliver tumor suppression gene.  \nIn recent years, phosphoinositide phosphohistidine inorganic pyrophosphate phosphatase (LHPP), a histidine phosphatase, has been shown to be a new tumor suppressor12.Low expression of LHPP has also been found in cancer tissues of bladder cancer13, lung cancer, pancreatic cancer14, 15, cervical cancer16, papillary thyroid cancer17, and colorectal cancer18, 19. Overexpression of LHPP protein inhibits hepatocellular carcinoma cell growth and metastasis, and also reduces the transcription of CCM1, PKM2, MMP7, and MMP9 in cancer cells, and that high expression of LHPP was negatively correlated with cell cycle and metastasis, among others20. It suggests that LHPP is lung cancer suppressor with potent.  \nIn this study, we constructed a novel ","cbCaikudNxBS7Q62","https://ap.wps.com/l/cbCaikudNxBS7Q62","pdf",2220397,"English","# Background\n## Need for novel lung cancer therapies\n## Tumor-targeting oncolytic virotherapy\n# Study design\n## Construction of GD55-LHPP\n## LHPP biology and rationale\n# Results\n## Low expression of LHPP in lung cancer\n## GD55-LHPP mediates LHPP expression and inhibits growth\n## Mechanistic insights: apoptosis and autophagy\n# In vivo efficacy\n## Xenograft tumor suppression and survival outcomes","[{\"question\":\"What is GD55-LHPP and what is its therapeutic goal?\",\"answer\":\"GD55-LHPP is a recombinant oncolytic adenovirus where GD55 carries the LHPP gene. Its goal is to mediate LHPP expression in lung cancer cells and suppress tumor growth.\"},{\"question\":\"How do the results compare LHPP expression in lung cancer versus normal tissues?\",\"answer\":\"LHPP expression is lower in lung cancer cells and in clinical lung cancer tissues compared with normal cells and tissues, indicating an association between LHPP loss and lung cancer.\"},{\"question\":\"What mechanisms does GD55-LHPP use to inhibit lung cancer progression?\",\"answer\":\"GD55-LHPP induces stronger apoptosis through caspase signal pathway activation and also activates an autophagy-related signal pathway.\"}]","Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer | PDF",1790020828,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87c0199d0f2081c0a95081b801c74076.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db2340615417a08563698de42b95f50a.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4aafedea651e8c8f116cb01088b3aaed.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fe401c6485e5b07626c7bb084e07ac9.webp",980,1287]